BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2026 6:07:05 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-09-25 06:02 |
|
Peer-Review Started |
|
2025-09-25 06:03 |
|
First Decision by Editorial Office Director |
|
2025-10-23 08:59 |
|
Return for Revision |
|
2025-10-23 08:59 |
|
Revised |
|
2025-12-04 18:43 |
|
Publication Fee Transferred |
|
2025-12-03 00:44 |
|
Second Decision by Editor |
|
2026-02-13 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-13 07:20 |
|
Articles in Press |
|
2026-02-13 07:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-06 02:37 |
|
Publish the Manuscript Online |
|
2026-03-27 06:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mexan Mapouka, Evariste Pabingui, Nkengeh N Tazinkeng, Milkessa Gurmessa, Ulrich Vickos, Nkafu Bechem Ndemazie and Serge Magloire Camengo Police |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mexan Mapouka, MD, Department of Internal Medicine, University of Maryland Capital Region Medical Center, 901 Harry S Truman Dr, Largo, MD 20774, United States. mexan.mapouka@umm.edu |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Lean obesity; Liver fibrosis; Metabolic dysfunction-associated steatohepatitis; Mortality |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease affects both lean and non-lean individuals. This meta-analysis of over 10 million participants found that non-lean patients had greater odds of hepatic steatosis, fibrosis, cirrhosis, and hypertension. Lean patients, however, showed similar risks of nonalcoholic steatohepatitis, cardiovascular disease, and mortality. These results support expanding metabolic dysfunction-associated steatotic liver disease screening and risk assessment beyond obesity-related criteria. |
| Publish Date |
2026-03-27 06:07 |
| Citation |
Mapouka M, Pabingui E, Tazinkeng NN, Gurmessa M, Vickos U, Ndemazie NB, Camengo Police SM. Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(13): 114657 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i13/114657.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i13.114657 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
